Physician profile
Angela Tempesta
NPI 1013397710
$522.89
in general payments reported to CMS, 2019-2025
9 companies · $335 in 2025
The $335 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $21.38 · 2023: $65.68 · 2024: $101 · 2025: $335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $502.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $501.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $189.60 | 2024-2025 | |
| Alcon Vision LLC | $91.77 | 2022-2025 | Clareon, Precision 1 |
| Tarsus Pharmaceuticals, INC. | $80.50 | 2024-2025 | Xdemvy |
| Johnson & Johnson Vision Care, INC. | $41.21 | 2023-2025 | Acuvue |
| Sandoz INC. | $32.12 | 2024 | Cimerli |
| Novartis Pharmaceuticals Corporation | $28.50 | 2023 | |
| Sun Pharmaceutical Industries INC. | $21.85 | 2025 | |
| Ocular Therapeutix, INC. | $20.49 | 2024 | Dextenza |
| Johnson & Johnson Surgical Vision, INC. | $16.85 | 2025 | Tecnis Iol, Tecnis Iol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Tempesta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.